A comparative study of depression and anxiety in psoriasis and other chronic skin diseases
Keywords:
Depression, anxiety, psoriasisAbstract
Background Psoriasis is often associated with psychological disorders and social discomfort. Objective To compare depression and subcomponents of anxiety among psoriasis patients and controls with other chronic skin disorders. Patients and methods 162 psoriasis patients and 200 patients with other chronic skin disorders in the age group of 14-60 years were selected from Dermatology & Venereology Outpatient Department of Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar. The participants responded to IPAT Anxiety scale and Zungs Self-Rating Depression Scale. The data was analyzed statistically. Results The results of present study clearly revealed that psoriasis patients scored higher on depression and different sub-components of anxiety namely low self control, suspicion, apprehension and tension as compared to the control group. Conclusions The findings of the present study highlight the higher prevalence of depression and anxiety in the psoriasis patients as compared to patients with other chronic skin diseases; it also shows importance of psychological adjustment in patient with psoriasis. It is recommended that the patients with psoriasis require psychological evaluation and management along with medical treatment.ÂReferences
Lal S. Clinical pattern of psoriasis in Punjab. Indian J Dermatol Venereol 1966; 35: 5-12.
Root S, Kent G, Al’Abadie MS. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994; 189: 234-7.
Picardi A, Abeni D, Melchi CF et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143:983-91.
Richards HL, Fortune DG, Griffiths CEM, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001; 50: 11-5.
Vardy D, Besser A, Amir M et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002; 147: 736-42.
de Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol 2001; 144 (suppl 58): 33-6.
O’Leary CJ, Creamer D, Higgins E, Weinman J. Perceived stress, stress attributions and psychological distress in psoriasis. J Psychosom Res 2004; 57: 465-71.
Garg A, Chren MM, Sands LP et al. Psychological stress perturbs epidermal permeability barrier homeostasis: implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 2001; 137: 53-9.
Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermatol 1999; 10: 119-26.
Selye H. The general adaption syndrome and the diseases of adaption. J Clin Endocrinol 1946; 6: 117-230.
Moore RY, Bloom FE. Central catecholamine neuron systems: Anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci 1979; 22: 113-68.
Palmblad JE. Stress related modulation of immunity. Cancer Detect Prev Suppl 1987; 1: 57-64.
Ashcroft DM, Li Wan Po A et al. Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther 1998; 23: 391-8.
Gelfand JM, Feldman SR, Stern RS et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51: 704-8.
Fortune DG, Main CJ, O’Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755-60.
Ekelund AG. The 7th congress on dermatological and Psychiatry: Bodily contact promotes peace of mind (CD-ROM) Medline. Abstract from Silver File3.11: Psychosomatic Dermatitis, 1995. Marked in Search of # 7.
Gupta MA, Schork NJ, Gupta AK et al. Suicidal ideation in psoriasis. Int J Dermatol 1993; 32: 188-90.
Esposito M, Saraceno R, Giunta A et al. An Italian study on psoriasis and depression. Dermatology 2006; 212: 123-7.
Devrimci-Ozguven H, Kundakci N, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 267-71.
Gupta MA, Gupta AK, Kirkby S et al. Pruritus in psoriasis: a prospective study of some psychiatric and dermatologic correlates. Arch Dermatol 1988; 124: 1052-7.
Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosomatic Medicine 1994; 56: 36-40.
Rakhesh SV, D’Souza M, Sahai A. Quality of life in psoriasis: a study from South India. Indian J Dermatol Venereol Leprol 2008; 74: 600-6.
Krueger G, Koo J, Lebwohl M et al. The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient membership survey. Arch Dermatol 2001; 137: 280-4.
McKenna KE, Stern RS. The impact of psoriasis on the quality of life of patients from a 16-center PUVA follow-up cohort. J Am Acad Dermatol 1997; 36: 388-94.
Van Voorhees AS, Fried R. Depression and quality of life in Psoriasis. Postgrad Med 2009; 121: 154-61.
